Quanta Pharma Telmisartan 40mg supplied as 60 tablets. Telmisartan is an angiotensin receptor blocker favoured in this context for genuine 24-hour coverage and partial PPAR-gamma activity, unusual for a blood pressure medication. UK dispatch, tracked delivery.
Quanta Pharma Telmisartan Specifications
Telmisartan 40mg by Quanta PharmaQuanta Pharma Telmisartan Research Areas
- Long half-life: Genuine 24-hour coverage, unlike shorter-acting ARBs
- Partial PPAR-gamma activity: Associated with favourable metabolic effects, unusual in this drug class
- Relevant on cycle: Fluid retention and raised haematocrit both push pressure up
- Measure, do not guess: Blood pressure produces no reliable symptoms until it is already dangerous
How Telmisartan Works
Telmisartan blocks the receptor angiotensin II acts on, relaxing blood vessels and lowering pressure. Its long half-life gives full-day coverage from a single dose.
On cycle, pressure rises from several directions at once, fluid retention from aromatising compounds, raised red cell count, and the eating and training that accompany a bulk.
Treat the Cause Before the Symptom
If pressure is being driven by fluid retention from an aromatising compound, controlling oestrogen properly addresses the cause. If it is driven by haematocrit, that is a different problem with a different answer.
Medicating around a compound you could adjust is the wrong order of operations.
Read Before You Buy
Why Choose Quanta Pharma Telmisartan?
Pharmaceutical-grade tablets, consistent presentation and a traceable brand. Dispatched from the UK with tracked delivery.
Note: this is a licensed medicine with real contraindications and interactions. Anyone using it should be doing so with medical oversight rather than guesswork.
⚠️ FOR LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE
Safety Classification:
For use by qualified research personnel only
Keep detailed records of usage and storage as per UK research regulations
Legal Notice: This product is exclusively intended for in vitro laboratory research conducted in controlled environments by trained professionals.




